Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.

Abstract

Sequential development of Leishmania braziliensis promastigotes from a noninfective to an infective stage was demonstrated. The generation of infective forms was related to their growth cycle and restricted to stationary stage organisms. Using immunofluorescence techniques, we have noticed that the binding of a monoclonal antibody (mAb) against L. braziliensis (VD5/25) increased progressively as the promastigotes developed in culture and was maximal with the infective forms. This antigenic differentiation was not detected with an anti-L. braziliensis polyclonal rabbit antiserum, suggesting that only a few epitopes, including that recognized by VD5/25, have their expression effectively increased on the surface of infective promastigotes. Immunoprecipitation of lysates of surface-iodinated L. braziliensis promastigotes with this mAb revealed two proteins of apparent 65,000 and 50,000 Mr, the 50,000 Mr protein probably representing the unreduced form of the major surface glycoprotein described in several species of Leishmania (GP65). The increasing expression of this epitope was not found with L. chagasi promastigotes, but seems to occur with the parasites from the L. mexicana complex. Intracellular survival of L. braziliensis was completely inhibited when the infective promastigotes were treated with VD5/25. It appears, therefore, that the increasing expression of GP65 on the promastigote surface represents an essential mechanism of leishmania survival in the macrophage.